MHS
AXSM icon

M Holdings Securities’s Axsome Therapeutics AXSM Stock Holding History

M Holdings Securities’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,275
Closed -$242K – 256
2021
Q1 		$242K Buy
+4,275
New +$301K 0.02% 429

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

M Holdings Securities's AXSM Position: Q2 2021 in Review

M Holdings Securities sold out of Axsome Therapeutics (AXSM) in Q2 2021, closing a stake of 4,275 shares — an estimated $242K sold.

M Holdings Securities first reported a position in AXSM in Q1 2021 and held it in 1 quarter. The position peaked at $242K in Q1 2021. 176 funds tracked by Wall St. Rank hold AXSM as of Q2 2021.

  • M Holdings Securities reported no remaining Axsome Therapeutics position as of Q2 2021 after selling out during the quarter.
  • M Holdings Securities sold 4,275 Axsome Therapeutics shares in Q2 2021, an estimated $242K.
  • M Holdings Securities first reported a position in Axsome Therapeutics in Q1 2021 and held it in 1 quarter.
  • M Holdings Securities's Axsome Therapeutics position peaked at $242K in Q1 2021.
  • 176 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2021.

Based on M Holdings Securities's 13F filing for Q2 2021, filed 19 Aug 2021.